Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 25, 2015
Pharmacy Choice - News - Over-the-Counter Drugs - May 25, 2015

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 14 of 14     Go To Page:

5/25/15 - Paragon BioTeck Enters Promotional Agreement to Expand Availability of ilast Portfolio of Products
By a News Reporter-Staff News Editor at Pharma Business Week Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, announced that it has entered into a multi-year agreement with global healthcare supplier Perrigo Company plc to promote the ilast range of products for eyelid hygiene in the United States.
5/22/15 - Strides Arcolab to Acquire Prescription Products from Aspen Global for USD92 million
Strides Arcolab Limited, a pharmaceutical company, through its wholly owned subsidiary Strides Pharma Global Pte Limited, has agreed to acquire a portfolio of six branded prescription products, from Aspen Global Incorporated, a pharmaceuticals company and wholly owned subsidiary of Aspen Pharmacare, for a purchase consideration of approximately USD
5/22/15 - U.S. FDA Approves INVEGA TRINZA, First and Only Four-Times-A-Year Treatment for Schizophrenia
Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved under priority review the New Drug Application for the three-month long-acting atypical antipsychotic INVEGA TRINZA. The results of the phase 3 study were published in March by JAMA Psychiatry, a peer-reviewed medical journal published by the American.
5/21/15 - Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million
Deal Type: Asset Transaction Deal Country: South Africa Deal Status: Announced Deal Value: 133.9840 USD. Aspen Pharmacare Ltd., a supplier of branded and generic pharmaceuticals and a wholly owned subsidiary of Aspen Pharmacare Holdings Ltd., intends to divest business unit which forms part of its pharmaceutical division to Litha Pharma Ltd., a div
5/21/15 - Ayotte, Gardner Introduce Bill Aimed at Increasing Availability of Safe and Effective Over-the-Counter Contraceptives
The Allowing Greater Access to Safe and Effective Contraception Act would incentivize manufacturers of routine-use contraceptives to file for a prescription-to-over-the-counter switch by allowing for priority review of the application and waiving the FDA filing fee. These incentives would be available for any contraceptive available to adults...
5/21/15 - Nutra Pharma Updates on Nyloxin Distribution Plans for Canada [Professional Services Close - Up]
Nutra Pharma Corp. reported that it has engaged the Nature's Clinic to begin the process of regulatory approval of the Company's Over-the-Counter pain drug, Nyloxin for marketing and distribution in Canada. "We recently announced our plans for distribution in India and China," stated Rik J Deitsch, Chairman and CEO of Nutra Pharma Corp. "I'm excit
5/20/15 - Antimicrobial Animal Drug Sales and Distribution Reporting
WASHINGTON, May 20 The Department of Health& Human Services published the following proposed rule in the Federal Register from the Food& Drug Administration:. A Proposed Rule by the Food and Drug Administration on 05/20/2015. The Animal Drug User Fee Amendments of 2008 amended the Federal Food, Drug, and Cosmetic Act to require that sponsors of a
5/19/15 - Lannett to Acquire Silarx Pharma for USD42 Million
Lannett Company, Inc., a developer, manufacturer and distributor of generic pharmaceutical products, has agreed to acquire Silarx Pharmaceuticals, Inc., a manufacturer of pharmaceutical products including generic prescription and over-the-counter products, from Rohit Desai and the RD Nevada Trust, for a purchase consideration of USD42 million in ca
5/19/15 - MedVantx Announces Pharmaceutical Industry's First Point-of-Care Medication Formulary Program for Health Systems and Accountable Care Organizations (ACOs).
MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect? program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment an
5/19/15 - Technology Catalysts International Reports on Rx-to-OTC Switch
As quoted in the Drug Store News, Joseph Papa, Perrigo chairman, CEO and president, believes that " Rx-to-OTC switches are expected to continue, with more than $10 billion in branded prescription sales likely to switch in the next five years.". Other factors in switch popularity are the FDA's consideration of ways that can make the transition of dr
5/19/15 - U.S. FDA Approves INVEGA TRINZA?, First and Only Four-Times-A-Year Treatment for Schizophrenia
Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved under priority review the New Drug Application for the three-month long-acting atypical antipsychotic INVEGA TRINZA?. The results of the phase 3 study were published in March by JAMA Psychiatry, a peer-reviewed medical journal published by the Americ
5/18/15 - Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader
DUBLIN and WOODCLIFF LAKE, N.J., May 18, 2015/ PRNewswire/. Transaction valued at $8.05 billion is transformative for Endo, creating a powerful platform for future growth and further strategic M&A Creates specialty pharmaceutical company with one of industry's fastest growing generics businesses and expanded product portfolio, pipeline, technolog
5/18/15 - New Real-World Data Show Adults with Type 2 Diabetes, Including Those Taking Multiple Diabetes Medications, Achieve Blood Glucose Treatment Goals After Using INVOKANA (canagliflozin)
The results presented today are among a total of 15 presentations related to INVOKANA made at the 20th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research in Philadelphia, held May 16 to 20. "These data show INVOKANA provides significant reductions in A1C in people with type 2 diabetes seen in everyday cli
5/18/15 - Summer Brings Fun in the Sun but Threats Lurk Beneath the Water's Surface
BALTIMORE, MD and TAMPA, FL 05/18/15 Romark Laboratories, a Tampa- based pharmaceutical company committed to the discovery, development and commercialization of innovative small molecules for treating infectious diseases, and Lupin Pharmaceuticals Inc., the 6th largest pharmaceutical company in the US with a wide portfolio of generic and bran
Articles(s): 1 - 14 of 14     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415